Epigenetic Regulation of Infant Neurobehavioral Outcomes

Area of Science:

• Neuroscience
• Epigenetics
• Developmental Biology

Background:

• Environmental factors during development can cause epigenetic alterations impacting neurobehavior and mental health.
• Epigenetic dysregulation, including genomic imprinting and microRNAs, is implicated in neurodevelopmental disorders like autism spectrum disorders (ASD).
• The placenta plays a crucial role in mediating the intrauterine environment and connecting maternal and fetal systems.

Purpose of the Study:

• To investigate the association between placental epigenetic signatures and newborn neurobehavioral development.
• To explore the role of DNA methylation in specific gene pathways (cortisol, serotonin, metabolic) and imprinted genes in relation to neurodevelopment.
• To understand the mechanisms linking epigenetics to neurodevelopment and mental health disorders.

Main Methods:

• Analysis of placental epigenetic signatures, including DNA methylation of key genes (e.g., NR3C1, HSD11B, HTR2A, LEP).
• Assessment of newborn neurobehavior using the NICU Network Neurobehavioral Scales (NNNS).
• Examination of imprinted genes and microRNAs associated with neurobehavioral outcomes.

Main Results:

• Placental epigenetic signatures were associated with newborn neurobehavioral development as measured by NNNS.
• Specific DNA methylation patterns in genes related to cortisol, serotonin, and metabolic pathways showed associations with neurobehavior.
• Dysregulation of imprinted genes and microRNAs correlated with neurobehavioral assessments.

Conclusions:

• Placental epigenetics serve as a potential indicator of fetal neurodevelopment.
• Epigenetic modifications, particularly DNA methylation, are linked to neurobehavioral outcomes in newborns.
• Further research is needed to elucidate the mechanisms and potential of epigenetic marks as biomarkers for mental health and cognitive function.